Serotonin toxicity as a consequence of linezolid use in revision hip arthroplasty

Orthopedics

Volumn 31, Issue 11, 2008, Pages 1140-

  Mason, Lyndon W ^a   Randhawa, Kiran S ^a,b   Carpenter, Eleanor C ^a  

^a UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^b NONE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LINEZOLID; RIFAMPICIN; SEROTONIN; VANCOMYCIN; VENLAFAXINE; ACETAMIDE DERIVATIVE; ANALGESIC AGENT; ANTIINFECTIVE AGENT; CYCLOHEXANOL DERIVATIVE; OXAZOLIDINONE DERIVATIVE; SEROTONIN UPTAKE INHIBITOR;

ACETABULUM; ADULT; ARTHROGRAPHY; ARTICLE; AUTONOMIC DYSFUNCTION; BONE SCINTISCANNING; CASE REPORT; CELL LABELING; CLINICAL DECISION MAKING; COMPUTER ASSISTED TOMOGRAPHY; CONFUSION; CONVALESCENCE; DEPRESSION; DETERIORATION; DEVICE REMOVAL; DISEASE COURSE; DISORIENTATION; DROWSINESS; DRUG WITHDRAWAL; EUPHORIA; FEMALE; FEVER; GENERAL CONDITION DETERIORATION; GENERAL CONDITION IMPROVEMENT; HIP ARTHROPLASTY; HIP PROSTHESIS; HUMAN; HYPERTENSION; HYPOMANIA; ISOTOPE LABELING; MENTAL DISEASE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NEUROMUSCULAR DISEASE; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; REOPERATION; SEROTONIN SYNDROME; SWEATING; TOTAL HIP PROSTHESIS; TREATMENT WITHDRAWAL; CHEMICALLY INDUCED DISORDER; DRUG CONTRAINDICATION; DRUG INTERACTION; METABOLISM; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATION;

ACETAMIDES; ADMINISTRATION, ORAL; ANALGESICS; ANTI-INFECTIVE AGENTS; ARTHROPLASTY, REPLACEMENT, HIP; CYCLOHEXANOLS; DRUG INTERACTIONS; FEMALE; HUMANS; MIDDLE AGED; OXAZOLIDINONES; POSTOPERATIVE COMPLICATIONS; SEROTONIN; SEROTONIN SYNDROME; SEROTONIN UPTAKE INHIBITORS;

EID: 65349130712     PISSN: 01477447     EISSN: None     Source Type: Journal    
DOI: 10.3928/01477447-20081101-17     Document Type: Article

References (11)

1. Rubinstein E, Isturiz R, Standiford HC, Smith LG, Oliphant TH, Cammaraia S. Worldwide assessment of linezolid's clinical safety and tolerability: comparator-controlled phase III studies. Antimicrob Agents Chemother. 2003; 47(6):1824-1831. (Pubitemid 36637801)
2. Sola CL, Bostwick JM, Hart DA, Lineberry TW. Anticipating potential linezolid-SSRI interactions in the general hospital setting: an MAOI in disguise. Mayo Clin Proc. 2006; 81(3):330-334. (Pubitemid 43334627)
3. Bergeron L, Boule M, Perreault S. Serotonin toxicity associated with concomitant use of linezolid. Ann Pharmacother. 2005; 39(5):956-961. (Pubitemid 40570678)
4. Lavery S, Ravi H, McDaniel WW, Pushkin YR. Linezolid and serotonin syndrome. Psychosomatics. 2001; 42(5):432-434. (Pubitemid 33032117)
5. Wigen CL, Goetz MB. Serotonin syndrome and linezolid. Clin Infect Dis. 2002; 34(12):1651-1652. 5. (Pubitemid 34615453)
6. Bernard L, Stern R, Lew D, Hoffmeyer P. Serotonin syndrome after concomitant treatment with linezolid and citalopram. Clin Infect Dis. 2003; 36(9):1197. (Pubitemid 36549644)
7. Tahir N. Serotonin syndrome as a consequence of drug-resistant infections: an interaction between linezolid and citalopram. J Am Med Dir Assoc. 2004; 5(2):111-113. (Pubitemid 38380411)
8. Clark DB, Andrus MR, Byrd DC. Drug interactions between linezolid and selective reuptake inhibitors: Case report involving sertraline and review of the literature. Pharmacotherapy. 2006; 26(2):269-276. (Pubitemid 43201875)
9. Ener RA, Meglathery SB, Van Decker WA, Gallagher RM. Serotonin syndrome and other serotonergic disorders. Pain Med. 2003; 4(1):63-74. (Pubitemid 37161330)
10. Sternbach H. The serotonin syndrome. Am J Psychiatry. 1991; 148(6):705-713.
11. Moellering RC. Linezolid: the first oxazolidinone antimicrobial. Ann Intern Med. 2003; 138(2):135-142. (Pubitemid 36222501)